BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹59 Cr | ₹57 Cr | ₹12 Cr | ₹23 Cr | ₹30 Cr |
What is the latest Contingent Liabilities ratio of BLISS GVS PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹59 Cr |
| Mar2024 | ₹57 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹23 Cr |
| Mar2021 | ₹30 Cr |
How is Contingent Liabilities of BLISS GVS PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹59 Cr | 3.45 | |
| Mar2024 | ₹57 Cr | 390.81 | |
| Mar2023 | ₹12 Cr | -48.95 | |
| Mar2022 | ₹23 Cr | -25.09 | |
| Mar2021 | ₹30 Cr | - | |
Compare Contingent Liabilities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹1,857.3 Cr | 22.2% | 9.8% | 3.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,982.0 Cr | -0.7% | -0.5% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,878.0 Cr | 2.8% | 2.2% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,095.0 Cr | 1.5% | 3.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹122,175.0 Cr | 0.8% | 0.1% | 3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,154.0 Cr | 0.4% | 3.2% | 0.3% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 22.2% |
9.8% |
3.4% |
| SENSEX | 0.4% |
-0.1% |
6.1% |
You may also like the below Video Courses